ClinicalTrials.Veeva

Menu

Study of the Interactions Between Dientamoba Fragilis and the Gut Microbiota

U

University Hospital, Strasbourg, France

Status

Terminated

Conditions

Diarrhea

Treatments

Other: Stool sampling and sequencing of gut microbiota.

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

D.fragilis is an intestinal protozoon that feeds by phagocytosis of intestinal bacteria. The study aim to determine if the carriage of the intestinal parasite D.fragilis is associated to changes of gut microbiota in subjects presenting with or without intestinal symptoms.

Enrollment

27 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for symptomatic group:

  • male/female aged at least of 18 years
  • subject with abdominal pain, diarrhea, bloating
  • no other known intestinal disease

Inclusion Criteria for asymptomatic group:

  • male/female aged at least of 18 years
  • no known intestinal disease

Exclusion Criteria of symptomatic and asymptomatic groups:

  • chronic intestinal diseases such as IBD, IBS ...
  • intake of antibiotic or probiotic within the 2 last months
  • subject in exclusion period
  • subject unable to understand information for a free consent to the study
  • subject in safeguarding justice or guardianship

Trial design

27 participants in 2 patient groups

Symptomatic subjects
Description:
Subjects with intestinal symptoms
Treatment:
Other: Stool sampling and sequencing of gut microbiota.
Asymptomatic subjects
Description:
Subjects without intestinal symptoms
Treatment:
Other: Stool sampling and sequencing of gut microbiota.

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems